Cladribine use in multiple sclerosis: a monocentric real-world experience

被引:0
|
作者
Pilotto, Silvy [1 ]
Mellino, Paolo [1 ]
Carmagnini, Daniele [1 ]
Frau, Jessica [1 ]
Coghe, Giancarlo [1 ]
Cocco, Eleonora [1 ]
Lorefice, Lorena [1 ]
机构
[1] Univ Cagliari, Binaghi Hosp, Dept Med Sci & Publ Hlth, Multiple Sclerosis Ctr,ASL Cagliari, Cagliari, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P743/1037
引用
收藏
页码:639 / 640
页数:2
相关论文
共 50 条
  • [1] Findings from a large monocentric real-world experience of Ocrelizumab use in Multiple Sclerosis
    Mellino, Paolo
    Pilotto, Silvy
    Frau, Jessica
    Carmagnini, Daniele
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 613 - 614
  • [2] Cladribine as treatment of multiple sclerosis, real world experience
    Celius, E. G.
    Berg-Hansen, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 527 - 528
  • [3] Evolution of teriflunomide use in multiple sclerosis: A real-world experience
    Lorefice, L.
    Pilotto, S.
    Fenu, G.
    Cimino, P.
    Firinu, D.
    Frau, J.
    Murgia, F.
    Coghe, G.
    Cocco, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 438
  • [4] Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)
    Arena, Sebastiano
    Chisari, Clara Grazia
    Toscano, Simona
    Bucello, Sebastiano
    Grimaldi, Luigi Maria
    Ragonese, Paolo
    Realmuto, Sabrina
    Cottone, Salvatore
    Maimone, Davide
    Finocchiaro, Chiara
    Reitano, Paola
    Patti, Francesco
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (07) : 1271 - 1283
  • [5] Real-world experience of oral cladribine use in the MSBase Registry
    Butzkueven, Helmut
    Spelman, Timothy
    Madueno, Sara Eichau
    Grand'Maison, Francois
    Kalincik, Tomas
    Hodgkinson, Suzanne
    Skibina, Olga
    Butler, Ernest
    NEUROLOGY, 2020, 94 (15)
  • [6] Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Lebson, Lori
    Piette, Elizabeth
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [7] Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study
    Rolfes, Leoni
    Pfeuffer, Steffen
    Huntemann, Niklas
    Schmidt, Mariella
    Su, Chuanxin
    Skuljec, Jelena
    Aslan, Derya
    Hackert, Jana
    Kleinschnitz, Konstanze
    Hagenacker, Tim
    Pawlitzki, Marc
    Ruck, Tobias
    Kleinschnitz, Christoph
    Meuth, Sven G.
    Pul, Refik
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [8] Immunological consequences of cladribine treatment in multiple sclerosis: a real-world study
    Rolfes, L.
    Pfeuffer, S.
    Huntemann, N.
    Schmidt, M.
    Su, C.
    Skuljec, J.
    Aslan, D.
    Hackert, J.
    Kleinschnitz, K.
    Hagenacker, T.
    Pawlitzki, M.
    Ruck, T.
    Kleinschnitz, C.
    Meuth, S. G.
    Pul, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 332 - 333
  • [9] 5 YEARS OF REAL-WORLD DATA ON THE USE OF CLADRIBINE TABLETS FOR THE TREATMENTS OF MULTIPLE SCLEROSIS IN PORTUGAL
    Ribeiro, M.
    Pinto, D.
    VALUE IN HEALTH, 2023, 26 (12) : S16 - S16
  • [10] Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
    Conway, Devon S.
    Nicholas, Jacqueline A.
    Thompson, Nicolas R.
    Mowry, Ellen M.
    Naismith, Robert T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94